The 2009 Frost & Sullivan Excellence in Technology Award for the U.S. Compression Therapy Market is presented to Circulator Boot Corporation in recognition of the company's innovative and proactive approach in improving arterial, venous and lymphatic circulation of the body. The creation of the Circulator Boot™ offers non-surgical treatment for non-responsive chronic wounds while also playing a crucial role in salvaging limbs at the risk of amputation.

Pioneering End-Diastolic Pneumatic Compression (EDPC)
The company has distinguished itself in the highly competitive compression therapy market with its revolutionary Circulator Boot™. Compared to traditional pneumatic compression devices, the Circulator Boot™ is designed to compress selective parts of the leg during the end-diastolic phase of the heart cycle or only when the heart is at rest. The device includes the Miniboot for distal therapy enclosing the foot and ankle, or the Longboot enclosing the leg from groin to toes, valve assembly and a heart monitor. Delivering compressions that are synchronized with the heart beat, the number of compressions per minute can be programmed to equal the pulse rate. Ideally a male patient would receive an average of 3200 compressions in a 40 minute schedule of therapy, which supersedes the performance of a traditional pneumatic compression device. The Circulator Boot™ is a highly versatile device which can be tuned to compress at every heartbeat, alternative heart beat, or every third heart beat. Also the device is equipped with significant flexibility capable of targeting compression to required parts of the leg or arm.

Optimum Clinical Outcomes Enhance Market Penetration
The Circulator Boot™ is the only end-diastolic pneumatic compression system approved by the FDA for treating peripheral arterial disease. Additional FDA indications include ischemic lesions, diabetic foot, lymphedema, venous stasis, rest pain and claudication. A comprehensive study covering a span of 15 years involving 1,035 patients with 2,177 different ischemic/lesion episodes found 8 out of 10 patients showed improvements in their conditions. Also, clinical studies evaluating the device have revealed an estimated 93.0 percent success rate in patients who underwent end-diastolic pneumatic compression therapy. Other noteworthy benefits include significant reduction and elimination in complications associated with poor circulation, enhanced stamina, tolerance to exercise, and marked improvements in overall patient quality of life. Mounting clinical data bolsters the clinical superiority of the device, which acts as a catalyst enhancing physician adoption of the product.

Moving Forward EDPC Therapy Set to Realize Full Potential
EDPC is covered under Medicare and private insurance in PA, NJ, DE, MD and Washington DC, with additional expansion expected this year. Doctors performing EDPC therapy have also reported receiving reimbursement in TN, OH, MO, MI, and MN. In addition, the therapy has been approved for use within the Veterans Administration Medical system. EDPC therapy with the Circulator Boot™ has evolved to be an efficient treatment modality for wound healing, poor circulation and limb preservation in diabetic patients. Armed with a unique technology which stands out from the rest of the traditional home use pneumatic systems, Circulator Boot Corporation is poised to continue its growth in the market and gain additional market share in years ahead.

Conclusion
Through the creation of an innovative and cost-effective solution, Circulator Boot Corporation positions itself at the forefront of patient care. Frost & Sullivan believes that the Circulator Boot Corporation's product development initiatives and supportive clinical data are likely to enhance the company's market penetration while also positively impact the quality of healthcare in the U.S.
Frost & Sullivan is proud to present the 2009 Excellence in Technology Award for the North American Compression Therapy Market to Circulator Boot Corporation.

 

Award Description
Frost & Sullivan's Excellence in Technology Award is bestowed upon the company that has pioneered the development and introduction of an innovative technology into the market; a technology that has either impacted or has the potential to impact several market sectors. This Award recognizes a company's successful technology development that is expected to bring significant contributions to the industry in terms of adoption, change, and competitive posture. It also recognizes the company's overall technical excellence and its commitment toward technology innovation.

Research Methodology
To choose the Award recipient, Frost & Sullivan's analyst team tracks technology innovation in key hi-tech markets. The selection process includes primary participant interviews and extensive primary and secondary research via the bottom-up approach. The analyst team shortlists candidates on the basis of a set of qualitative and quantitative measurements. The analysts also consider the pace of technology innovation, and the potential relevance or significance of the technology to the overall industry. The ultimate Award recipient is chosen after a thorough evaluation of this research.

Measurement Criteria
In addition to the methodology described above, there are specific criteria used to determine the final rankings. The recipient of this Award has excelled based on one or more of the following criteria:

 
About Best Practices
Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Frost & Sullivan
Frost & Sullivan, the Growth Consulting Company, partners with clients to accelerate their growth. The company's Growth Partnership Services, Growth Consulting and Career Best Practices empower clients to create a growth focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com